Bicarbonate Is Essential For Protein Tyrosine Phos
Bicarbonate Is Essential For Protein Tyrosine Phos
Bicarbonate Is Essential For Protein Tyrosine Phos
Protein-tyrosine phosphatases (PTPs) counteract protein Receptor-tyrosine kinase (RTK)4 activation leads to trans-
tyrosine phosphorylation and cooperate with receptor-tyro- mission of downstream phosphorylation cascades upon growth
sine kinases in the regulation of cell signaling. PTPs need to factor stimulation, and has major importance in physiology and
undergo oxidative inhibition for activation of cellular cas- proliferative diseases such as cancer. Protein-tyrosine phospha-
cades of protein-tyrosine kinase phosphorylation following tases (PTPs), including PTP1B, counteract protein tyrosine
growth factor stimulation. It has remained enigmatic how phosphorylation and thereby act together with RTKs to regulate
such oxidation can occur in the presence of potent cellular cell signaling (1). PTP activity depends upon a conserved ac-
reducing systems. Here, using in vitro biochemical assays tive-site Cys residue (1–4), which renders these enzymes suscep-
with purified, recombinant protein, along with experiments tible to oxidative inactivation. This has physiological importance,
in the adenocarcinoma cell line A431, we discovered that because RTK activation triggers transient H2O2 production
bicarbonate, which reacts with H2O2 to form the more reac- from NADPH oxidases (NOXs) (5), which in turn leads to
tive peroxymonocarbonate, potently facilitates H2O2-medi- reversible oxidation and inhibition of PTPs. Inactivation of
ated PTP1B inactivation in the presence of thioredoxin PTPs is believed to be absolutely required for RTK signaling (4,
reductase 1 (TrxR1), thioredoxin 1 (Trx1), and peroxiredoxin 6). NOXs are membrane-localized (typically on the plasma,
2 (Prx2) together with NADPH. The cellular experiments endosomal, or endoplasmic reticulum membrane) and use
revealed that intracellular bicarbonate proportionally dic- cytoplasmic NADPH to produce superoxide and H2O2 on the
tates total protein phosphotyrosine levels obtained after opposing membrane surface. The H2O2 must then enter the
stimulation with epidermal growth factor (EGF) and that cell, facilitated through aquaporins (7, 8), to exert its signaling
bicarbonate levels directly correlate with the extent of PTP1B actions. During stimulation of platelet-derived growth factor
oxidation. In fact, EGF-induced cellular oxidation of PTP1B and epidermal growth factor (EGF) receptor pathways, the cat-
was completely dependent on the presence of bicarbonate. alytic Cys residue of PTP1B becomes reversibly oxidized and
These results provide a plausible mechanism for PTP inacti- thus inhibited (4, 9). The initial oxidation product is a sulfenic
vation during cell signaling and explain long-standing obser- acid (-SOH) (10, 11), which can condense to an internal sulfe-
vations that growth factor responses and protein phosphory- nylamide (12–14) or undergo glutathionylation (15, 16).
lation cascades are intimately linked to the cellular acid– base Reversibly oxidized PTP1B can be reactivated by the thiore-
balance. doxin (Trx) system (thioredoxin reductase 1 (TrxR1) and
NADPH with or without Trx1 or thioredoxin-related protein of
14 kDa (TRP14) (10, 17–19), thus enabling the Trx system to
modulate cellular RTK signaling (17).
This work was supported by the Karolinska Institutet, the Knut and Alice Wal- It is much debated exactly how oxidation of PTP1B occurs in
lenberg Foundations, the Swedish Cancer Society, the Karolinska Institutet a cellular environment, especially considering that members of
Research Foundations (to E. S. J. A.), Swedish Research Council Grant
(to E. S. J. A. and M. D.) 537-2014-360, Swedish Society of Medicine Grant
the peroxiredoxin (Prx) family of thiol proteins, which are
SLS-786841, Åke Wiberg Stiftelse Grants M17-0101 and M18-0141 (to expressed at high levels in cells and also recycled predominantly
M. D.), National Institutes of Health Grant HL138605, American Heart Asso- by the Trx/TrxR/NADPH system, are many orders of magni-
ciation Grant 17GRNT33700265 (to B. B.), and the New Zealand Marsden tude more reactive and therefore likely to react with nearly all
Fund (to C. C. W.). The authors declare that they have no conflicts of interest
with the contents of this article. The content is solely the responsibility of intracellular H2O2 (20 –22). Some cytosolic thiol-containing
the authors and does not necessarily represent the official views of proteins can be oxidized via Prx-mediated relays (23, 24), but
the National Institutes of Health.
This article was selected as one of our Editors’ Picks.
This article contains Figs. S1–S4.
1 4
To whom correspondence may be addressed. E-mail: [email protected]. The abbreviations used are: RTK, receptor-tyrosine kinase; PTP, protein-ty-
2
To whom correspondence may be addressed. E-mail: Christine.Winterbourn@ rosine phosphatase; EGF, epidermal growth factor; Trx, thioredoxin; Prx,
otago.ac.nz. peroxiredoxin; NBC, sodium and bicarbonate exchanger protein; NOX,
3
To whom correspondence may be addressed. E-mail: [email protected]. NADPH oxidase.
This is an open access article under the CC BY license.
H 2 O 2 ⫹ CO 2 /HCO ⫺ ⫺ ⫹
3 ª HCO 4 ⫹ H /H 2 O
Reaction 1
Figure 2. Modulation of bicarbonate- and H2O2-dependent inactivation of PTP1B in the presence of a Prx2/TrxR1/Trx1 redox system. A, scheme
showing relevant reactions in the experimental PTP1B/Prx2/thioredoxin system. Sox of PTP1B could be either the sulfenic acid or sulfenylamide species, with
the former also reducible by TrxR/NADPH in the absence of Trx. B, PTP1B (600 nM) was treated with 50 M H2O2 together with 25 mM bicarbonate in the presence
of Trx1 (5 M), Prx2 (10 M), NADPH (300 M), and increasing TrxR1 concentrations of 0 nM (f), 2 nM (Œ), 10 nM (), 50 nM (⽧), 250 nM (E), and 1 M (䡺) and with
1 M TrxR1 using buffer-treated control without H2O2 (F). PTP activity was measured after the indicated times. Data points represent means ⫾ S.D. (error bars)
(n ⫽ 3). C, analyses were performed as in B with TrxR1 (1 M) and increasing Trx1 concentration, 0 M (⽧), 0.5 M (), 1 M (Œ), 2 M (f), and 5 M (F) (n ⫽ 1).
D, analyses performed as in A with TrxR1 (15 nM) and increasing concentrations of bicarbonate as indicated, 0 mM (f), 5 mM (Œ), 10 mM (), 15 mM (⽧), 25 mM
(E), 35 mM (䡺), and 45 mM (‚) (n ⫽ 1).
inactivation (Fig. 1B). Notably, bicarbonate alone had no effect 2D). These results show that there is an interplay between
(Fig. 1B, control). We next examined whether inclusion of bicarbonate, PTP1B, and the Trx/Prx redox cycling systems
bicarbonate facilitated H2O2-mediated inactivation of PTP1B and that there are conditions whereby bicarbonate, presumably
in the presence of a functional Trx system. through the spontaneous production of peroxymonocarbonate
(33), promotes transient inactivation of PTP1B by H2O2. To
H2O2 and bicarbonate in combination can overcome rule out possible inhibitory effects of bicarbonate and H2O2 on
protection of PTP1B activity by the Trx/Prx system the Trx system, NADPH consumption was measured using
As reported previously, in the absence of bicarbonate, Prx2/ insulin as a substrate (46). The results showed no difference in
Trx1/TrxR1/NADPH (at 10, 2, 0.5, and 200 M, respectively) consumption by bicarbonate alone or in combination with
fully protects PTP1B against inactivation by 100 M H2O2 (25). H2O2 as compared with buffer control (Fig. S2).
This is due to a combination of H2O2 removal by the peroxidase
activity of Prx2 and reduction of the sulfenic acid and sulfenyl- Inhibition of bicarbonate cotransporters in A431 cells
amide forms of PTP1B by TrxR1 and Trx1, as illustrated in Fig. decreases EGF-induced phosphorylation cascades
2A. In the presence of bicarbonate (25 mM), where HCO⫺ 4 can We next addressed whether the mechanism identified with
cause faster PTP1B inactivation, Prx2/Trx1/TrxR1/NADPH at the purified enzymes applies to cellular systems, by examining
the same concentrations still gave almost complete protection the effect of bicarbonate on protein phosphorylation cascades
(Fig. 2B, 1 M TrxR1). However, by lowering the TrxR1 concen- triggered by growth factor stimulation. We used human A431
tration (Fig. 2B) or Trx1 concentration (Fig. 2C), it was possible epidermal squamous carcinoma cells, as these cells are known
to obtain conditions where PTP1B was inactivated for the dura- to inactivate PTP1B by oxidation in response to treatment with
tion of the experiment or inactivated at early time points, fol- EGF (10, 47). Extracellularly produced bicarbonate is trans-
lowed by a time-dependent regain in activity during the assay. ported into cells through membrane-bound cotransporter pro-
The latter pattern is reminiscent of the transient PTP1B inac- teins, NBCs, that control intracellular bicarbonate levels and
tivation expected to occur in cells during an oxidative burst thereby cellular pH (40). We thus stimulated A431 cells with
after growth factor stimulation. A higher concentration of pH- EGF ligand for 2, 4, and 6 min with or without 1-h pretreatment
adjusted bicarbonate (45 mM, pH 7.4) was also able to fully with S0859, a well-characterized inhibitor of NBCs (48). As
overcome the complete protection of PTP1B against 50 M shown in Fig. 3 (A and B), EGF ligand induced a rapid increase
H2O2 provided by the cycling Prx/Trx system, as seen by a rapid in total protein tyrosine phosphorylation, primarily associated
and sustained loss of PTP1B activity (Fig. 2D). At intermediate with the ⬃198 kDa band representing the EGF receptor (Fig.
concentrations of bicarbonate, maintaining the same pH, H2O2 3A). This phosphorylation was notably inhibited when bicar-
caused transient PTP1B inactivation followed by recovery (Fig. bonate influx was blocked with S0859. The EGFR phosphory-
Figure 4. Treatment of A431 cells with lactic acid prior to EGF ligand stimulation results in less phosphorylation. A, concentration dependence.
Serum-starved A431 cells in regular DMEM containing bicarbonate were pretreated for 2 min with 0, 5, 10, 20, and 40 mM lactic acid and subsequently
stimulated with EGF (100 ng/ml) for 5 min. Lysates were analyzed for total phosphotyrosine. B, time course. A431 cells were pretreated for 2 min with 0, 15, and
30 mM lactic acid and subsequently stimulated with EGF (100 ng/ml) for 2, 4, and 6 min. Lysates were analyzed for total phosphotyrosine. The right-hand panels
in A and B show densitometry analyses as in Fig. 3 with filled circles showing individual results (n ⫽ 3; mean ⫾ S.D. (error bars); *, p ⬍ 0.05). The membranes in
this figure stained with Ponceau for total protein loading are shown in Fig. S4.
present. We used all reactants at physiologically relevant con- vated as the H2O2 is consumed and the reducing mechanisms
centrations and were able to vary conditions within these to see dominate.
transient inactivation and reactivation, reminiscent of a signal- To test the relevance of this mechanism of PTP1B inactiva-
ing step. We propose a mechanism to explain these results in tion during EGF-triggered signaling context, we modulated the
which H2O2 can either be scavenged by Prx2 or react with cellular bicarbonate levels using three different approaches.
bicarbonate to generate peroxymonocarbonate, which is Lowering bicarbonate uptake with the NBC inhibitor S0859
responsible for PTP1B inactivation (Fig. 2A). Increasing the resulted in less EGFR-dependent protein tyrosine phosphory-
bicarbonate favors the latter, whereas regeneration of reduced lation in A431 cells. Likewise, the addition of lactic acid, which
Prx2 by the thioredoxin system enhances H2O2 removal and is lowers bicarbonate levels by a shift in acid– base equilibrium,
protective. It is possible that peroxymonocarbonate could also also decreased phosphotyrosine levels following EGF ligand
react with Prx2 in this system. However, we have recently found stimulation in a dose-dependent manner. These observations
that oxidation of the reduced protein is unaffected by the pres- are compatible with the notion that lower intracellular levels of
ence of bicarbonate.5 Although hyperoxidation was enhanced, bicarbonate give less inhibition of cellular PTP activity, but
this would cause only minor inactivation of the Prx2 under the other effects of acidification could not be excluded. However,
conditions of our current study. Nevertheless, in other situa- the experiments with cells grown in pH-controlled HEPES-
tions, this could amplify the effect on PTP1B. Complementing buffered DMEM revealed signaling effects of bicarbonate not
these oxidative reactions are the reductive steps involving related to changes in pH.
reduction of Prx2 disulfide to maintain its scavenging activity as Our results collectively suggest a molecular mechanism by
well as recycling of PTP1B, either through a reaction of the which physiological changes in bicarbonate levels affect
sulfenic acid intermediate directly with TrxR1 (25) or recycling
growth factor signaling responses. This conclusion is sub-
of the sulfenylamide by TrxR1 together with Trx1 or TRP14
stantiated by the finding that the cysteinyl-labeling assay
(17). The balance between these steps determines the extent to
detected EGF-dependent oxidation of PTP1B only in the
which PTP1B is initially inactivated and subsequently reacti-
presence of bicarbonate. Thus, bicarbonate seems to be an
obligate factor for EGF-dependent PTP1B oxidation. We
5
A. V. Peskin and C. C. Winterbourn, unpublished observations. hence propose a model for redox regulation of PTP1B during
Treatment of PTP1B with H2O2 and bicarbonate SDS-PAGE and analysis of protein tyrosine phosphorylation
Reduced PTP1B (600 nM) was pre-incubated for 20 min in 20 Treated cells were washed with ice-cold PBS (pH 7.4) and
mM HEPES, 100 mM NaCl buffer, pH 7.4, containing 0.1 mM lysed with lysis buffer (0.5% Triton X-100, 0.5% sodium deoxy-
EDTA, 0.05% BSA, 1 mM sodium azide, with the indicated con- cholate salt/deoxycholic acid, 150 mM NaCl, 20 mM Tris (pH
centrations of Trx1, TrxR1, NADPH (N7505, Sigma-Aldrich), 7.5), 10 mM EDTA, and 30 mM sodium pyrophosphate (pH 7.5),
and Prx2. Sodium azide was used to inhibit any trace amounts supplemented with 200 M sodium orthovanadate and a prote-
of catalase. Each reaction mixture was exposed to H2O2 with ase inhibitor mixture (Roche Applied Science)). Protein con-
and without bicarbonate for the indicated times. Bicarbon- centration of lysates was determined using the Bradford assay.
ate and H2O2 were premixed prior to treatment. Subsequent Equal amounts of lysate protein were resolved by SDS-PAGE,
to treatment, measurement of PTP activity was performed. transferred to polyvinylidene difluoride membranes (Milli-
pore), blocked with 5% milk in TBS, and immunoblotted for
PTP activity assay total phosphotyrosine 4G10 (Merck, catalog no. 05-321)
PTP activity was assessed using 15 mM chromogenic sub- (1:1000) and EGFR pTyr-992 (Cell Signaling). The total amount
strate 4-nitrophenyl phosphate (P4744, Sigma-Aldrich) as of loading was verified using Ponceau staining of blotted mem-
described previously (57). Rates of absorbance increase were branes or EGFR intensities (AF231, R&D Systems). Protein
measured at 410 nm at 22 °C using an Infinite M200 Pro plate phosphotyrosine intensities were quantified using ImageJ and
reader (Tecan) and calibrated using a 4-nitrophenol standard shown as a ratio of loading control, as described.
curve.
Detection of reversible PTP oxidation in cells
Treatment of PTP1B with H2O2 The cysteinyl-labeling assay of reversibly oxidized PTP1B
Buffer-exchanged reduced PTP1B was exposed to H2O2 and was performed as described previously (50, 51). The lysis buffer
different components of the Trx system at the indicated time (50 mM sodium acetate, pH 5.5, 150 mM NaCl, 10% glycerol, 1%
points followed by the addition of substrate and measurement Surfact-Amp Nonidet P-40, 5 g/ml aprotinin, 5 g/ml leupep-
of activity. We initially observed that incubation of PTP1B tin, 50 units/ml superoxide dismutase, 50 units/ml catalase, 10
alone resulted in some time-dependent inactivation that was mM iodoacetic acid) was degassed and placed on ice into a
partially prevented in the presence of BSA, so BSA (0.05%) was hypoxic glove-box station equilibrated with 100% argon. Cells
added to the buffer. The activity after each H2O2 treatment cultured in 100-mm dishes were treated and then transferred
was related to the activity of untreated PTP1B incubated for from a 37 °C/5% CO2 environment into a hypoxic glove-box
the same time. A 0 –24% loss of activity was seen in control station, medium was carefully removed, and cells were rapidly
conditions at 30 min. lysed with 800 l of ice-cold lysis buffer. Lysates were trans-
ferred to amber-colored microcentrifuge tubes and shaken for
Insulin-coupled TrxR assay 1 h at room temperature to alkylate reduced thiols. Protein
concentrations were determined, and 1 mg of lysate was applied
NADPH consumption was measured through incubation of
to a spin column to remove excess iodoacetic acid. Tris(2-car-
the Trx system (1 M TrxR1, 20 M Trx1, and 300 M NADPH)
boxyethyl)phosphine (1 mM) was then added to reduce revers-
together with 0.16 mM insulin in 20 mM HEPES, 100 mM NaCl
ibly oxidized protein thiols. Following this step, 5 mM EZ-link
buffer, pH 7.4, containing 0.1 mM EDTA, 0.05% BSA with and
iodoacetyl-PEG2-biotin probe (Pierce) was added to the lysate
without 25 mM bicarbonate and 100 M H2O2.
to label the reactivated thiols. Labeled proteins were then
Cell culture conditions and treatments pulled down by streptavidin-Sepharose beads, which were
washed with lysis buffer (pH 5.5), resuspended in 20 l of 4⫻
Adenocarcinoma cell line A431 cells (ATCC) were typically, Laemmli sample buffer, and heated at 90 °C for 90 s. Samples
unless stated otherwise, cultured in DMEM (44 mM sodium were resolved by SDS-PAGE and blotted with anti-PTP1B.
bicarbonate, 5% CO2) ⫹ 10% (v/v) fetal bovine serum, 2 mM Immunoblots of total cell lysates were run as controls.
L-glutamine, penicillin, and streptomycin. Cells were grown
until 90% confluence and then starved for 24 h in 0.1% fetal Statistical analyses
bovine serum. Pretreatment of starved cells prior to ligand
Analyses of data were performed using GraphPad Prism with
stimulation was performed with the indicated concentrations
two-way analysis of variance followed by Bonferroni post hoc
of either lactic acid (Sigma-Aldrich, catalog no. L6402), S0859
tests for multiple comparisons.
(Sigma-Aldrich, catalog no. SML0638), or sodium bicarbonate
(Merck, catalog no. 9018415). Ligand stimulations were per-
Author contributions—M. D. performed a majority of the experi-
formed with 100 ng/ml EGF ligand (R&D Systems, catalog no.
ments and analysis of data and contributed to writing the paper.
236-EG-200). For cell culture conditions with varying concen- Q. C. expressed and purified TrxR1 and Trx1. S. H. M. R. performed
trations of bicarbonate, bicarbonate-free DMEM (D5648) the CLA assay. P. E. P. expressed Prx2. B. B. performed the CLA
(0.1% (v/v) FBS, 2 mM L-glutamine, penicillin, and streptomy- assay and provided intellectual input. C. C. W. designed experi-
cin) was supplemented with 50 mM HEPES and 0, 40, and 60 mM ments, analyzed data, provided essential intellectual input, and con-
bicarbonate, set to pH 7.4, and pre-equilibrated in 0, 5, and 10% tributed to writing the paper. E. S. J. A. was responsible for the pro-
CO2, respectively, for 3 days prior to the addition to cells, as ject overall and contributed to design of experiments, analyzed data,
stated above. provided intellectual input, and wrote the paper.
18. Schwertassek, U., Haque, A., Krishnan, N., Greiner, R., Weingarten, L.,
Acknowledgment—We thank Dr. Mark Hampton for helpful Dick, T. P., and Tonks, N. K. (2014) Reactivation of oxidized PTP1B and
PTEN by thioredoxin 1. FEBS J. 281, 3545–3558 CrossRef Medline
discussions.
19. Parsons, Z. D., and Gates, K. S. (2013) Thiol-dependent recovery of cata-
lytic activity from oxidized protein tyrosine phosphatases. Biochemistry
52, 6412– 6423 CrossRef Medline
References
20. Antunes, F., and Brito, P. M. (2017) Quantitative biology of hydrogen
1. Tonks, N. K. (2006) Protein tyrosine phosphatases: from genes, to func- peroxide signaling. Redox Biol. 13, 1–7 CrossRef Medline
tion, to disease. Nat. Rev. Mol. Cell Biol. 7, 833– 846 CrossRef Medline 21. Denu, J. M., and Tanner, K. G. (1998) Specific and reversible inactivation
2. Alonso, A., Sasin, J., Bottini, N., Friedberg, I., Friedberg, I., Osterman, A., of protein tyrosine phosphatases by hydrogen peroxide: evidence for a
Godzik, A., Hunter, T., Dixon, J., and Mustelin, T. (2004) Protein tyrosine sulfenic acid intermediate and implications for redox regulation. Biochem-
phosphatases in the human genome. Cell 117, 699 –711 CrossRef Medline istry 37, 5633–5642 CrossRef Medline
3. Andersen, J. N., Mortensen, O. H., Peters, G. H., Drake, P. G., Iversen, L. F., 22. Winterbourn, C. C. (2008) Reconciling the chemistry and biology of reac-
Olsen, O. H., Jansen, P. G., Andersen, H. S., Tonks, N. K., and Møller, N. P. tive oxygen species. Nat. Chem. Biol. 4, 278 –286 CrossRef Medline
(2001) Structural and evolutionary relationships among protein tyrosine 23. Sobotta, M. C., Liou, W., Stöcker, S., Talwar, D., Oehler, M., Ruppert, T.,
phosphatase domains. Mol. Cell. Biol. 21, 7117–7136 CrossRef Medline Scharf, A. N., and Dick, T. P. (2015) Peroxiredoxin-2 and STAT3 form a
4. Frijhoff, J., Dagnell, M., Godfrey, R., and Ostman, A. (2014) Regulation of redox relay for H2O2 signaling. Nat. Chem. Biol. 11, 64 –70 CrossRef
protein tyrosine phosphatase oxidation in cell adhesion and migration. Medline
Antioxid. Redox Signal. 20, 1994 –2010 CrossRef Medline 24. Stöcker, S., Maurer, M., Ruppert, T., and Dick, T. P. (2018) A role for 2-Cys
5. Lambeth, J. D. (2004) NOX enzymes and the biology of reactive oxygen. peroxiredoxins in facilitating cytosolic protein thiol oxidation. Nat. Chem.
Nat. Rev. Immunol. 4, 181–189 CrossRef Medline Biol. 14, 148 –155 CrossRef Medline
6. Ostman, A., Frijhoff, J., Sandin, A., and Böhmer, F. D. (2011) Regulation of 25. Dagnell, M., Pace, P. E., Cheng, Q., Frijhoff, J., Östman, A., Arnér, E. S. J.,
protein tyrosine phosphatases by reversible oxidation. J. Biochem. 150, Hampton, M. B., and Winterbourn, C. C. (2017) Thioredoxin reductase 1
345–356 CrossRef Medline and NADPH directly protect protein tyrosine phosphatase 1B from inac-
7. Bertolotti, M., Farinelli, G., Galli, M., Aiuti, A., and Sitia, R. (2016) AQP8 tivation during H2O2 exposure. J. Biol. Chem. 292, 14371–14380 CrossRef
transports NOX2-generated H2O2 across the plasma membrane to pro- Medline
mote signaling in B cells. J. Leukoc. Biol. 100, 1071–1079 CrossRef 26. Krishnan, N., Bonham, C. A., Rus, I. A., Shrestha, O. K., Gauss, C. M.,
Medline Haque, A., Tocilj, A., Joshua-Tor, L., and Tonks, N. K. (2018) Harnessing
8. Medraño-Fernandez, I., Bestetti, S., Bertolotti, M., Bienert, G. P., Bottino, insulin- and leptin-induced oxidation of PTP1B for therapeutic develop-
C., Laforenza, U., Rubartelli, A., and Sitia, R. (2016) Stress regulates aqua- ment. Nat. Commun. 9, 283 CrossRef Medline
porin-8 permeability to impact cell growth and survival. Antioxid. Redox 27. Krishnan, N., Koveal, D., Miller, D. H., Xue, B., Akshinthala, S. D., Kragelj,
Signal. 24, 1031–1044 CrossRef Medline J., Jensen, M. R., Gauss, C. M., Page, R., Blackledge, M., Muthuswamy,
9. Tanner, J. J., Parsons, Z. D., Cummings, A. H., Zhou, H., and Gates, K. S. S. K., Peti, W., and Tonks, N. K. (2014) Targeting the disordered C termi-
(2011) Redox regulation of protein tyrosine phosphatases: structural and nus of PTP1B with an allosteric inhibitor. Nat. Chem. Biol. 10, 558 –566
chemical aspects. Antioxid. Redox Signal. 15, 77–97 CrossRef Medline CrossRef Medline
10. Lee, S. R., Kwon, K. S., Kim, S. R., and Rhee, S. G. (1998) Reversible inac- 28. Bakhmutova-Albert, E. V., Yao, H., Denevan, D. E., and Richardson, D. E.
tivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with (2010) Kinetics and mechanism of peroxymonocarbonate formation. In-
epidermal growth factor. J. Biol. Chem. 273, 15366 –15372 CrossRef org. Chem. 49, 11287–11296 CrossRef Medline
Medline 29. Trindade, D. F., Cerchiaro, G., and Augusto, O. (2006) A role for peroxy-
11. Frijhoff, J., Dagnell, M., Augsten, M., Beltrami, E., Giorgio, M., and Öst- monocarbonate in the stimulation of biothiol peroxidation by the bicar-
man, A. (2014) The mitochondrial reactive oxygen species regulator bonate/carbon dioxide pair. Chem. Res. Toxicol. 19, 1475–1482 CrossRef
p66Shc controls PDGF-induced signaling and migration through protein Medline
tyrosine phosphatase oxidation. Free Radic. Biol. Med. 68, 268 –277 30. Adam, A., and Mehta, M. (1998) KH(O2)CO2H2O2: an oxygen-rich salt of
CrossRef Medline monoperoxocarbonic acid. Angew. Chem. Int. Ed. Engl. 37, 1387–1388
12. van Montfort, R. L., Congreve, M., Tisi, D., Carr, R., and Jhoti, H. (2003) CrossRef Medline
Oxidation state of the active-site cysteine in protein tyrosine phosphatase 31. Richardson, D. E., Regino, C. A., Yao, H., and Johnson, J. V. (2003) Methi-
1B. Nature 423, 773–777 CrossRef Medline onine oxidation by peroxymonocarbonate, a reactive oxygen species
13. Salmeen, A., Andersen, J. N., Myers, M. P., Meng, T. C., Hinks, J. A., Tonks, formed from CO2/bicarbonate and hydrogen peroxide. Free Radic. Biol.
N. K., and Barford, D. (2003) Redox regulation of protein tyrosine phos- Med. 35, 1538 –1550 CrossRef Medline
phatase 1B involves a sulphenyl-amide intermediate. Nature 423, 32. Balagam, B., and Richardson, D. E. (2008) The mechanism of carbon di-
769 –773 CrossRef Medline oxide catalysis in the hydrogen peroxide N-oxidation of amines. Inorg.
14. Sivaramakrishnan, S., Cummings, A. H., and Gates, K. S. (2010) Protection Chem. 47, 1173–1178 CrossRef Medline
of a single-cysteine redox switch from oxidative destruction: on the func- 33. Zhou, H., Singh, H., Parsons, Z. D., Lewis, S. M., Bhattacharya, S.,
tional role of sulfenyl amide formation in the redox-regulated enzyme Seiner, D. R., LaButti, J. N., Reilly, T. J., Tanner, J. J., and Gates, K. S.
PTP1B. Bioorg Med. Chem. Lett. 20, 444 – 447 CrossRef Medline (2011) The biological buffer bicarbonate/CO2 potentiates H2O2-medi-
15. Rinna, A., Torres, M., and Forman, H. J. (2006) Stimulation of the alveolar ated inactivation of protein tyrosine phosphatases. J. Am. Chem. Soc.
macrophage respiratory burst by ADP causes selective glutathionylation 133, 15803–15805 CrossRef Medline
of protein tyrosine phosphatase 1B. Free Radic. Biol. Med. 41, 86 –91 34. Gorbatenko, A., Olesen, C. W., Boedtkjer, E., and Pedersen, S. F. (2014)
CrossRef Medline Regulation and roles of bicarbonate transporters in cancer. Front. Physiol.
16. Barrett, W. C., DeGnore, J. P., König, S., Fales, H. M., Keng, Y. F., Zhang, 5, 130 CrossRef Medline
Z. Y., Yim, M. B., and Chock, P. B. (1999) Regulation of PTP1B via gluta- 35. Hynes, N. E., and MacDonald, G. (2009) ErbB receptors and signaling
thionylation of the active site cysteine 215. Biochemistry 38, 6699 – 6705 pathways in cancer. Curr. Opin. Cell Biol. 21, 177–184 CrossRef Medline
CrossRef Medline 36. Grandis, J. R., and Sok, J. C. (2004) Signaling through the epidermal growth
17. Dagnell, M., Frijhoff, J., Pader, I., Augsten, M., Boivin, B., Xu, J., Mandal, factor receptor during the development of malignancy. Pharmacol. Ther.
P. K., Tonks, N. K., Hellberg, C., Conrad, M., Arnér, E. S., and Östman, A. 102, 37– 46 CrossRef Medline
(2013) Selective activation of oxidized PTP1B by the thioredoxin system 37. Wang, X., Batty, K. M., Crowe, P. J., Goldstein, D., and Yang, J. L. (2015)
modulates PDGF- receptor tyrosine kinase signaling. Proc. Natl. Acad. The potential of panHER inhibition in cancer. Front. Oncol. 5, 2 CrossRef
Sci. U.S.A. 110, 13398 –13403 CrossRef Medline Medline
38. Dorai, T., Sawczuk, I. S., Pastorek, J., Wiernik, P. H., and Dutcher, J. P. bicarbonate cotransport in the heart. Br. J. Pharmacol. 153, 972–982
(2005) The role of carbonic anhydrase IX overexpression in kidney cancer. CrossRef Medline
Eur. J. Cancer 41, 2935–2947 CrossRef Medline 49. Milarski, K. L., Zhu, G., Pearl, C. G., McNamara, D. J., Dobrusin, E. M.,
39. Svastova, E., and Pastorekova, S. (2013) Carbonic anhydrase IX: a hypoxia- MacLean, D., Thieme-Sefler, A., Zhang, Z. Y., Sawyer, T., and Decker, S. J.
controlled “catalyst” of cell migration. Cell Adh. Migr. 7, 226 –231 (1993) Sequence specificity in recognition of the epidermal growth factor
CrossRef Medline receptor by protein tyrosine phosphatase 1B. J. Biol. Chem. 268,
40. Aalkjaer, C., Boedtkjer, E., Choi, I., and Lee, S. (2014) Cation-coupled 23634 –23639 Medline
bicarbonate transporters. Compr. Physiol. 4, 1605–1637 CrossRef 50. Boivin, B., Zhang, S., Arbiser, J. L., Zhang, Z. Y., and Tonks, N. K. (2008) A
Medline modified cysteinyl-labeling assay reveals reversible oxidation of protein
41. Gorbatenko, A., Olesen, C. W., Mørup, N., Thiel, G., Kallunki, T., Valen, tyrosine phosphatases in angiomyolipoma cells. Proc. Natl. Acad. Sci.
E., and Pedersen, S. F. (2014) ErbB2 upregulates the Na⫹,HCO3⫺-cotrans- U.S.A. 105, 9959 –9964 CrossRef Medline
porter NBCn1/SLC4A7 in human breast cancer cells via Akt, ERK, Src, 51. Boivin, B., Yang, M., and Tonks, N. K. (2010) Targeting the reversibly
and Kruppel-like factor 4. FASEB J. 28, 350 –363 CrossRef Medline oxidized protein tyrosine phosphatase superfamily. Sci. Signal. 3, pl2
42. Boedtkjer, E., Moreira, J. M., Mele, M., Vahl, P., Wielenga, V. T., Chris- CrossRef Medline
52. Meng, T. C., Buckley, D. A., Galic, S., Tiganis, T., and Tonks, N. K. (2004)
tiansen, P. M., Jensen, V. E., Pedersen, S. F., and Aalkjaer, C. (2013) Con-
Regulation of insulin signaling through reversible oxidation of the protein-
tribution of Na⫹,HCO3⫺-cotransport to cellular pH control in human
tyrosine phosphatases TC45 and PTP1B. J. Biol. Chem. 279, 37716 –37725
breast cancer: a role for the breast cancer susceptibility locus NBCn1
CrossRef Medline
(SLC4A7). Int. J. Cancer 132, 1288 –1299 CrossRef Medline
53. Wood, Z. A., Poole, L. B., and Karplus, P. A. (2003) Peroxiredoxin evolu-
43. McIntyre, A., Hulikova, A., Ledaki, I., Snell, C., Singleton, D., Steers, G.,
tion and the regulation of hydrogen peroxide signaling. Science 300,
Seden, P., Jones, D., Bridges, E., Wigfield, S., Li, J. L., Russell, A., Swietach,
650 – 653 CrossRef Medline
P., and Harris, A. L. (2016) Disrupting hypoxia-induced bicarbonate trans-
54. Parks, S. K., Chiche, J., and Pouyssegur, J. (2011) pH control mechanisms
port acidifies tumor cells and suppresses tumor growth. Cancer Res. 76, of tumor survival and growth. J. Cell. Physiol. 226, 299 –308 CrossRef
3744 –3755 CrossRef Medline Medline
44. Lee, S., Axelsen, T. V., Andersen, A. P., Vahl, P., Pedersen, S. F., and Boedtkjer, 55. Xu, J., Eriksson, S. E., Cebula, M., Sandalova, T., Hedström, E., Pader, I.,
E. (2016) Disrupting Na⫹, HCO3⫺-cotransporter NBCn1 (Slc4a7) delays mu- Cheng, Q., Myers, C. R., Antholine, W. E., Nagy, P., Hellman, U., Se-
rine breast cancer development. Oncogene 35, 2112–2122 CrossRef Medline livanova, G., Lindqvist, Y., and Arnér, E. S. (2015) The conserved Trp114
45. Hulikova, A., Vaughan-Jones, R. D., and Swietach, P. (2011) Dual role of residue of thioredoxin reductase 1 has a redox sensor-like function trig-
CO2/HCO3⫺ buffer in the regulation of intracellular pH of three-dimen- gering oligomerization and crosslinking upon oxidative stress related to
sional tumor growths. J. Biol. Chem. 286, 13815–13826 CrossRef Medline cell death. Cell Death Dis. 6, e1616 CrossRef Medline
46. Arner, E. S., and Holmgren, A. (2001) Measurement of thioredoxin and 56. Nagy, P., Karton, A., Betz, A., Peskin, A. V., Pace, P., O’Reilly, R. J., Hamp-
thioredoxin reductase. Curr. Protoc. Toxicol. Chapter 7, Unit 7.4 Medline ton, M. B., Radom, L., and Winterbourn, C. C. (2011) Model for the ex-
47. Lou, Y. W., Chen, Y. Y., Hsu, S. F., Chen, R. K., Lee, C. L., Khoo, K. H., Tonks, ceptional reactivity of peroxiredoxins 2 and 3 with hydrogen peroxide: a
N. K., and Meng, T. C. (2008) Redox regulation of the protein tyrosine phos- kinetic and computational study. J. Biol. Chem. 286, 18048 –18055
phatase PTP1B in cancer cells. FEBS J. 275, 69 – 88 CrossRef Medline CrossRef Medline
48. Ch’en, F. F., Villafuerte, F. C., Swietach, P., Cobden, P. M., and Vaughan- 57. Montalibet, J., Skorey, K. I., and Kennedy, B. P. (2005) Protein tyrosine
Jones, R. D. (2008) S0859, an N-cyanosulphonamide inhibitor of sodium- phosphatase: enzymatic assays. Methods 35, 2– 8 CrossRef Medline